Table 4.
Adverse Events in Intent To Treat Population
| Control | Low-dose (500 mg/daily) |
High-dose (4000 mg/daily) |
Total | |
|---|---|---|---|---|
| Number of patients | 23 | 55 | 47 | 125 |
| Patients experiencing adverse events | 19 (83%) |
38 (69%) |
32 (68%) |
89 (71%) |
| Adverse events (definitely related) | 0 | 0 | 1 | 1 |
| Adverse events (probably related) | 1 | 2 | 0 | 3 |
| Adverse events (possibly related) | 3 | 8 | 10 | 21 |
Patients may have experienced more than one AE.